{"id":17699,"date":"2021-09-30T09:14:08","date_gmt":"2021-09-30T09:14:08","guid":{"rendered":"https:\/\/www.neuraxpharm.com\/ie\/?page_id=17699"},"modified":"2023-05-24T08:00:06","modified_gmt":"2023-05-24T08:00:06","slug":"pharmacovigilance","status":"publish","type":"page","link":"https:\/\/www.neuraxpharm.com\/ie\/pharmacovigilance","title":{"rendered":"Pharmacovigilance"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Pharmacovigilance<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Reporting an Adverse Drug Reaction <\/strong><\/p>

If you suspect a possible adverse reaction related to any of Neuraxpharm’s products, you can contact our Pharmacovigilance department directly:<\/p>

  • Email: pv-ireland@neuraxpharm.com<\/li>
  • Phone number: +353 818 021 044<\/li><\/ul>

    Medical Information <\/strong><\/p>

    If you have any medical questions related to any of our products, you can also contact us through:<\/p>

    • Email: medinfo-ireland@neuraxpharm.com<\/li>
    • Phone number: +353 818 021 044<\/li><\/ul>

      \u00a0<\/p>

      Your personal data will be processed by Neuraxpharm. For more information about our Privacy Policy, please click here.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

      Pharmacovigilance Reporting an Adverse Drug Reaction If you suspect a possible adverse reaction related to any of Neuraxpharm’s products, you can contact our Pharmacovigilance department directly: Email: pv-ireland@neuraxpharm.com Phone number: +353 818 021 044 Medical Information If you have any medical questions related to any of our products, you can also contact us through: Email: […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"elementor_header_footer","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-17699","page","type-page","status-publish","hentry"],"yoast_head":"\nPharmacovigilance - Neuraxpharm IE<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.neuraxpharm.com\/pharmacovigilance\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharmacovigilance\" \/>\n<meta property=\"og:description\" content=\"Pharmacovigilance Reporting an Adverse Drug Reaction If you suspect a possible adverse reaction related to any of Neuraxpharm’s products, you can contact our Pharmacovigilance department directly: Email: pv-ireland@neuraxpharm.com Phone number: +353 818 021 044 Medical Information If you have any medical questions related to any of our products, you can also contact us through: Email: […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.neuraxpharm.com\/pharmacovigilance\" \/>\n<meta property=\"og:site_name\" content=\"Neuraxpharm IE\" \/>\n<meta property=\"article:modified_time\" content=\"2023-05-24T08:00:06+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.neuraxpharm.com\/ie\/pharmacovigilance\",\"url\":\"https:\/\/www.neuraxpharm.com\/pharmacovigilance\",\"name\":\"Pharmacovigilance - Neuraxpharm IE\",\"isPartOf\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/ie\/#website\"},\"datePublished\":\"2021-09-30T09:14:08+00:00\",\"dateModified\":\"2023-05-24T08:00:06+00:00\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.neuraxpharm.com\/pharmacovigilance\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.neuraxpharm.com\/ie\/#website\",\"url\":\"https:\/\/www.neuraxpharm.com\/ie\/\",\"name\":\"Neuraxpharm IE\",\"description\":\"A European Leader for the CNS products\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.neuraxpharm.com\/ie\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Pharmacovigilance - Neuraxpharm IE","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.neuraxpharm.com\/pharmacovigilance","og_locale":"en_US","og_type":"article","og_title":"Pharmacovigilance","og_description":"Pharmacovigilance Reporting an Adverse Drug Reaction If you suspect a possible adverse reaction related to any of Neuraxpharm’s products, you can contact our Pharmacovigilance department directly: Email: pv-ireland@neuraxpharm.com Phone number: +353 818 021 044 Medical Information If you have any medical questions related to any of our products, you can also contact us through: Email: […]","og_url":"https:\/\/www.neuraxpharm.com\/pharmacovigilance","og_site_name":"Neuraxpharm IE","article_modified_time":"2023-05-24T08:00:06+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.neuraxpharm.com\/ie\/pharmacovigilance","url":"https:\/\/www.neuraxpharm.com\/pharmacovigilance","name":"Pharmacovigilance - Neuraxpharm IE","isPartOf":{"@id":"https:\/\/www.neuraxpharm.com\/ie\/#website"},"datePublished":"2021-09-30T09:14:08+00:00","dateModified":"2023-05-24T08:00:06+00:00","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.neuraxpharm.com\/pharmacovigilance"]}]},{"@type":"WebSite","@id":"https:\/\/www.neuraxpharm.com\/ie\/#website","url":"https:\/\/www.neuraxpharm.com\/ie\/","name":"Neuraxpharm IE","description":"A European Leader for the CNS products","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.neuraxpharm.com\/ie\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/www.neuraxpharm.com\/ie\/wp-json\/wp\/v2\/pages\/17699","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.neuraxpharm.com\/ie\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.neuraxpharm.com\/ie\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/ie\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/ie\/wp-json\/wp\/v2\/comments?post=17699"}],"version-history":[{"count":21,"href":"https:\/\/www.neuraxpharm.com\/ie\/wp-json\/wp\/v2\/pages\/17699\/revisions"}],"predecessor-version":[{"id":18089,"href":"https:\/\/www.neuraxpharm.com\/ie\/wp-json\/wp\/v2\/pages\/17699\/revisions\/18089"}],"wp:attachment":[{"href":"https:\/\/www.neuraxpharm.com\/ie\/wp-json\/wp\/v2\/media?parent=17699"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}